Bobby Kalb1, David Becker-Weidman2, Surya Chundru1, James Costello1, Puneet Sharma1, Khalil Salman1, Hina Arif1, Diego R. Martin1
1Radiology, University of Arizona, College of Medicine, Tucson, AZ, United States; 2Radiology, Emory University Department of Medicine, Atlanta, GA, United States
Reduction of post-transplant recurrence of hepatocellular carcinoma (HCC) is optimized by strict pre-transplant tumor staging (Milan criteria); however post-transplant tumor recurrence still occurs in up to 10% of patients with optimal preoperative staging. Imaging methodologies that are better able to predict recurrence risk of HCC from pretransplant imaging would be valuable in the triage of donor organs. Our study investigates potential imaging features on MRI that may provide added prognostic information regarding the biological behaviour of HCC, with the aim to better predict posttransplant recurrence.